Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Light Sciences Oncology - making light-activated drug therapy a commercial reality

This article was originally published in Scrip

Executive Summary

As Dr Keltner pulled out what looked like a computer mouse from his briefcase, I was surprised to hear him say it was in fact Litx, the company's innovative light-activated drug technology. It didn't look like an innovative light-activated drug treatment for solid tumours, as LSO describes it. And it looked more like a device than a drug. So what was its relevance to the pharmaceutical industry?

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

SC000708

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel